| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.053 | 0.8 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.096 | 0.8 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |